NGA NGUYEN: Open Payments
NPI 1376705202 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,051 in 90 payments from 20 companies in 2025. Trend: 2023 $2,021 · 2024 $2,615 · 2025 $2,051
Food & beverage: $1,889Education: $162
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $336 |
| Novartis Pharmaceuticals Corporation | 11 | $292 |
| Arcutis Biotherapeutics, Inc. | 12 | $246 |
| ABBVIE INC. | 14 | $200 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $179 |
| GENZYME CORPORATION | 3 | $115 |
| E.R. Squibb & Sons, L.L.C. | 6 | $108 |
| Lilly USA, LLC | 5 | $100 |
| Incyte Corporation | 5 | $100 |
| Organon LLC | 3 | $71 |
Products named: TREMFYA, Zoryve, COSENTYX, DUPIXENT, RINVOQ, Sotyktu, ILUMYA, OPZELURA.
Industry payments across TX — which companies pay providers there.
